Inventor · disambiguated record
Martin Goulet
Also filed as: GOULET MARTIN
6 granted patents·8 pending applications·18 citations·filing 2004–2023
74Inventor score
Top patents by PatentIndex Score
14 records- 0193US10843562B2Steering system for a vehicle having a magnetic paddle shift systemKA GROUP AG·Filed 2020·Granted Nov 24, 2020·15 cites·20 claims
- 0287US11512327B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2018·Granted Nov 29, 2022·3 cites·24 claims
- 0378US2024285667A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0476US12305189B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2022·Granted May 20, 2025·0 cites·6 claims
- 0574US12146150B2Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous deliveryVOYAGER THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 0665US2019365793A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0760US12491267B2Gene therapy for neurodegenerative disordersBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Granted Dec 9, 2025·0 cites·29 claims
- 0860US12281321B2Frataxin expression constructs having engineered promoters and methods of use thereofVOYAGER THERAPEUTICS INC·Filed 2019·Granted Apr 22, 2025·0 cites·42 claims
- 0954US2020263199A1Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous deliveryVOYAGER THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1054US2018021364A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1151US2005002922A1Use of secretin and secretin analogs to treat affective disordersFiled 2004·Application pending·0 cites
- 1250US2023136245A1Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacementPAROS BIO INC·Filed 2021·Application pending·0 cites
- 1343US2022339270A1Compositions and methods for the treatment of tauopathyVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1440US2019055578A1Delivery of central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →